THE FUTURE SYSTEM LEGISLATION FOR THE MARKETING AUTHORIZATION AND SUPERVISION IN MEDICINAL PRODUCTS WITHIN THE COMMUNITY

被引：0
|
作者：
BLASIUS, H
机构：
来源：
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS | 1994年 / 40卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：185 / 186
页数：2
相关论文
共 26 条
  • [1] EEC MARKETING AUTHORIZATION OF MEDICINAL PRODUCTS
    MIKHAIL, M
    [J]. TIERARZTLICHE UMSCHAU, 1992, 47 (05): : 387 - &
  • [2] Marketing authorization of veterinary medicinal products in Poland
    SztabinskaKoncka, H
    Lewicki, J
    [J]. REGULATORY TOXICOLOGY AND PHARMACOLOGY, 1997, 26 (01) : 129 - 133
  • [3] NOTICE TO APPLICANTS FOR MARKETING AUTHORIZATION FOR MEDICINAL PRODUCTS FOR HUMAN USE IN THE EC UPDATED
    BLASIUS, H
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 1993, 39 (06) : 269 - 271
  • [4] Homeopathic medicinal products in Germany and Europe: Legal requirements for registration and marketing authorization
    Keller, K
    [J]. DRUG INFORMATION JOURNAL, 1998, 32 (03): : 803 - 811
  • [5] Homeopathic Medicinal Products in Germany and Europe: Legal Requirements for Registration and Marketing Authorization
    Konstantin Keller
    [J]. Drug information journal : DIJ / Drug Information Association, 1998, 32 (3): : 803 - 811
  • [6] Legal possibility of marketing authorization and commercialization of advanced therapy medicinal products in Brazil
    Obici Garcia, Luisa Abreu
    Mendes Takao, Marilia Rodrigues
    Parca, Renata Miranda
    da Silva Junior, Joao Batista
    [J]. VIGILANCIA SANITARIA EM DEBATE-SOCIEDADE CIENCIA & TECNOLOGIA, 2018, 6 (01): : 6 - 14
  • [7] Failure due to formal reasons within German benefit assessment of medicinal products: the dilemma between marketing authorization and HTA
    Molitor, Markus
    Dintsios, Charalabos-Markos
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (01) : 145 - 157
  • [8] DECISION-MAKING ON MARKETING AUTHORIZATION OF ADVANCED THERAPY MEDICINAL PRODUCTS IN THE EUROPEAN UNION
    de Wilde, S.
    Coppens, D.
    de Bruin, M. L.
    Leufkens, H. G.
    Guchelaar, H.
    Hoekman, J.
    Meij, P.
    [J]. CYTOTHERAPY, 2017, 19 (05) : S63 - S63
  • [9] EUROPEAN REGULATORY CONTROLS AFFECTING APPLICATIONS FOR MARKETING AUTHORIZATION FOR IMMUNOLOGICAL VETERINARY MEDICINAL PRODUCTS
    IRWIN, V
    [J]. IRISH VETERINARY JOURNAL, 1995, 48 (11-12) : 419 - 422
  • [10] EU decision-making for marketing authorization of advanced therapy medicinal products: a case study
    de Wilde, Sofieke
    Coppens, Delphi G. M.
    Hoekman, Jarno
    de Bruin, Marie L.
    Leufkens, Hubert G. M.
    Guchelaar, Henk-Jan
    Meij, Pauline
    [J]. DRUG DISCOVERY TODAY, 2018, 23 (07) : 1328 - 1333
123